TrialJournal of cancer research and clinical oncology2022

The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer.

Chun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.